Evaluating equality in prescribing Novel Oral Anticoagulants (NOACs) in England: The protocol of a Bayesian small area analysis.

by Ehsan Rezaei-Darzi, Parinaz Mehdipour, Mariachiara Di Cesare, Farshad Farzadfar, Shadi Rahimzadeh, Lisa Nissen, Alireza Ahmadvand
Published 2021-01-01

Evaluation of productivity in Iranian pharmaceutical companies: A DEA-based Malmquist approach and panel data analysis

by Mehdi Varmaghani, Amir Hashemi Meshkini, Farshad Farzadfar, Mehdi Yousefi, Saeed Yaghoubifard, Vida Varahrami, Ehsan Rezaei Darzi, Majid Anabi, Abbas Kebriaeezadeh, Hedieh-Sadat Zekri
Published 2015-01-01

Prevalence of cardio-metabolic risk factors in a nationally representative sample of Iranian adolescents: The CASPIAN-III Study

by Roya Kelishadi, Ramin Heshmat, Farshad Farzadfar, Mohammad Esmaeil Motlagh, Maryam Bahreynian, Saeid Safiri, Gelayol Ardalan, Ehsan Rezaei Darzi, Hamid Asayesh, Fatemeh Rezaei, Mostafa Qorbani
Published 2017-03-01

A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial

by Gholamreza Toogeh, Mohammad Faranoush, Seyed Mohsen Razavi, Hassan Jalaeikhoo, Abolghasem Allahyari, Mohammad Reza Ravanbod, Fariba Zarrabi, Vahid Fallahazad, Ehsan Rezaei Darzi, Shadi Sadat Alizadeh Fard
Published 2018-04-01